CRIS Current Research Information System

TRAZZI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.838
AS - Asia 3.795
EU - Europa 3.042
AF - Africa 351
Continente sconosciuto - Info sul continente non disponibili 173
SA - Sud America 152
OC - Oceania 5
Totale 11.356
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.743
IT - Italia 1.368
VN - Vietnam 1.160
SG - Singapore 983
CN - Cina 795
GB - Regno Unito 398
DE - Germania 320
HK - Hong Kong 303
SE - Svezia 175
NL - Olanda 155
IN - India 130
FR - Francia 109
BD - Bangladesh 107
IE - Irlanda 106
BR - Brasile 105
TG - Togo 90
SC - Seychelles 89
KR - Corea 83
CI - Costa d'Avorio 75
RU - Federazione Russa 75
FI - Finlandia 55
ZA - Sudafrica 50
CA - Canada 48
ES - Italia 45
JP - Giappone 45
BG - Bulgaria 41
JO - Giordania 37
CH - Svizzera 35
PH - Filippine 29
ID - Indonesia 26
UA - Ucraina 26
AT - Austria 25
NG - Nigeria 25
AR - Argentina 22
TR - Turchia 22
EE - Estonia 21
BE - Belgio 18
TH - Thailandia 18
PL - Polonia 14
MX - Messico 13
PK - Pakistan 9
TW - Taiwan 9
DK - Danimarca 8
HR - Croazia 8
JM - Giamaica 8
MY - Malesia 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
IR - Iran 6
MA - Marocco 6
AU - Australia 5
IQ - Iraq 5
PE - Perù 5
SM - San Marino 5
TT - Trinidad e Tobago 5
VE - Venezuela 5
CO - Colombia 4
CZ - Repubblica Ceca 4
LB - Libano 4
PT - Portogallo 4
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
MD - Moldavia 3
NI - Nicaragua 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
EC - Ecuador 2
GH - Ghana 2
GT - Guatemala 2
NO - Norvegia 2
NP - Nepal 2
PR - Porto Rico 2
UY - Uruguay 2
UZ - Uzbekistan 2
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GI - Gibilterra 1
IS - Islanda 1
KE - Kenya 1
KY - Cayman, isole 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
Totale 11.177
Salva come PNG Salva come JPEG
Città #
Singapore 737
Bologna 485
Ashburn 465
Chandler 337
Ho Chi Minh City 302
Fairfield 290
Hong Kong 266
Southend 255
Hanoi 247
San Jose 196
Hefei 175
Santa Clara 157
Houston 149
Woodbridge 131
Wilmington 129
Dong Ket 128
Seattle 127
Ann Arbor 110
Dublin 105
Beijing 98
Council Bluffs 98
Boardman 92
Dallas 91
Lomé 90
Cambridge 87
Abidjan 75
Seoul 75
Los Angeles 73
Princeton 72
Turin 63
Milan 59
Frankfurt am Main 58
New York 56
Bristol 55
Helsinki 41
Rome 40
Rimini 39
Sofia 39
Amman 37
Lauterbourg 37
Falls Church 34
Redmond 34
Buffalo 33
Tokyo 32
Trento 31
Islington 29
Haiphong 28
Westminster 28
Marano 27
Nanjing 27
Berlin 26
Da Nang 26
Munich 26
Bern 25
Padova 25
Amsterdam 23
Argelato 21
Johannesburg 21
San Diego 21
Abeokuta 20
Orem 20
Bremen 19
Bengaluru 18
Vienna 18
Brussels 17
Chicago 16
Toronto 16
Bonn 15
Guangzhou 15
Hebei 15
Jerez De La Frontera 15
Modena 15
Redondo Beach 15
Shanghai 15
Biên Hòa 14
Bolzano 14
Castel Maggiore 14
Changsha 14
Saint Petersburg 14
Jakarta 13
Redwood City 13
Tianjin 13
Nanchang 12
Florence 11
Mumbai 11
San Francisco 11
São Paulo 11
Warsaw 11
Des Moines 10
Falkenstein 10
Forlì 10
Hải Dương 10
Jinan 10
Wuhan 10
Bari 9
London 9
Memphis 9
Bắc Giang 8
Denver 8
Medford 8
Totale 7.219
Salva come PNG Salva come JPEG
Nome #
Inhibition of microglia over-activation restores neuronal survival and maturation in a mouse model of CDKL5 deficiency disorder 402
Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder 371
Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death 353
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder 342
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease 327
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 315
A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder 304
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 303
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder 299
Functional impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are ameliorated by a GABAB receptor antagonist 294
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder 264
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 261
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder 260
The C-Terminal Domain of CENP-C Displays Multiple and Critical Functions for Mammalian Centromere Formation. 255
Artificial protein and its applications 254
CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling (vol 29, pg 658, 2019) 252
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder 246
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder 245
Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons 244
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 230
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 228
CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells 221
Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist 219
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 218
The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for down syndrome. 216
Treatment with the GSK3-beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice 213
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder 209
APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome. 207
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder 207
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder 207
Functional cooperation between TrkA and p75NTR accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities 206
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 202
Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer's disease 193
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 189
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 188
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome 187
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling. 179
DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions 178
Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression 172
CENP-C binds the alpha-satellite DNA in vivo at specific centromere domains 160
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 159
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/GSK-3{beta}/{beta}-catenin signaling 158
Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation. 153
Adult-Onset Deletion of CDKL5 in Forebrain Glutamatergic Neurons Impairs Synaptic Integrity and Behavior in Mice 149
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 142
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder 133
null 130
Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiency 117
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome 116
In vivo functional dissection of human inner kinetochore protein CENP-C 114
null 101
A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoids 64
Totale 11.356
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022819 0 0 73 70 86 56 42 57 44 78 166 147
2022/20231.420 111 227 74 168 120 122 38 81 228 33 110 108
2023/2024552 27 40 23 55 28 100 71 62 44 23 28 51
2024/20251.653 104 165 141 144 208 93 100 58 80 168 109 283
2025/20264.608 394 626 347 299 468 196 547 178 794 287 274 198
2026/2027280 154 124 2 0 0 0 0 0 0 0 0 0
Totale 11.356